Activation of NF-κB and c-jun transcription factors in multiple sclerosis lesions -: Implications for oligodendrocyte pathology

被引:139
作者
Bonetti, B [1 ]
Stegagno, C
Cannella, B
Rizzuto, N
Moretto, G
Raine, CS
机构
[1] Univ Verona, Sez Neurol Clin, Dipartimento Sci Neurol & Vis, Osped Policlin Borgo Roma, I-37134 Verona, Italy
[2] Albert Einstein Coll Med, Dept Pathol Neuropathol, Bronx, NY 10467 USA
[3] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA
关键词
D O I
10.1016/S0002-9440(10)65456-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Oligodendrocytes are a major target of the purported autoimmune response in multiple sclerosis (MS) lesions, but little is known about the mechanisms underlying their demise. Despite the expression of pro-apoptotic receptors, these cells are rarely seen to undergo apoptosis in situ, On the other hand, cytotoxic mediators present in MS lesions, such as tumor necrosis factor-alpha, are known to generate survival signals through the activation of the transcription factors NF-kappa B and c-jun, The aim of this study was to investigate in chronic active and silent MS lesions and control white matter the expression of c-jun, its activating molecule, JNK, as well as NF-kappa B complex and its inhibitor, I kappa B, By immunohistochemistry we found negligible reactivity for these molecules in control white matter and silent MS plaques. In active MS lesions, double-label immunohistochemistry with oligodendrocyte markers showed up-regulation of the nuclear staining for both NF-kappa B and JNK on a large proportion of oligodendrocytes located at the edge of active lesions and on microglia/macrophages throughout plaques. Oligodendrocytes showed no reactivity for I kappa B, which was predominantly confined to the cytoplasm of microglia/macrophages. We hypothesize that activation of these transcriptional pathways may be one mechanism accounting for the paucity of oligodendrocyte apoptosis reported in MS.
引用
收藏
页码:1433 / 1438
页数:6
相关论文
共 30 条
[1]   Synergistic stimulation of MHC class I and IRF-1 gene expression by IFN-γ and TNF-α in oligodendrocytes [J].
Agresti, C ;
Bernardo, A ;
Del Russo, N ;
Marziali, G ;
Battistini, A ;
Aloisi, F ;
Levi, G ;
Coccia, EM .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 (09) :2975-2983
[2]  
Amer A., 1996, SCIENCE, V274, P782
[3]   Apoptosis in brain-specific autoimmune disease [J].
Bauer, J ;
Wekerle, H ;
Lassmann, H .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (06) :839-843
[4]  
Bauerle PA, 1996, CELL, V87, P13
[5]   Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis [J].
Bonetti, B ;
Raine, CS .
ANNALS OF NEUROLOGY, 1997, 42 (01) :74-84
[6]  
DSOUZA S, 1995, J NEUROSCI, V15, P7293
[7]   Multiple sclerosis: Fas signaling in oligodendrocyte cell death [J].
DSouza, SD ;
Bonetti, B ;
Balasingam, V ;
Cashman, NR ;
Barker, PA ;
Troutt, AB ;
Raine, CS ;
Antel, JP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (06) :2361-2370
[8]  
GRILLI M, 1993, INT REV CYTOL, V143, P1
[9]   Transcription factor NF-κB and inhibitor IκBα are localized in macrophages in active multiple sclerosis lesions [J].
Gveric, D ;
Kaltschmidt, C ;
Cuzner, ML ;
Newcombe, J .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (02) :168-178
[10]   The c-Jun transcription factor - Bipotential mediator of neuronal death, survival and regeneration [J].
Herdegen, T ;
Skene, P ;
Bahr, M .
TRENDS IN NEUROSCIENCES, 1997, 20 (05) :227-231